Clinical Trial Update: Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of subcutaneous ketamine for depressive episodes with suicidal ideation/behavior in adolescents; currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicidal Ideation

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Depressive Disorder, Suicidal Ideas | Phase 3 | Status: NOT_YET_RECRUITING